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Shiga toxin-producing *Escherichia coli* (STEC) organisms cause intestinal disease characterized by hemorrhagic colitis (HC) that may progress to hemolytic uremic syndrome ([@B1]). STEC O157:H7 is the serotype most frequently associated with both sporadic cases and large outbreaks of HC in the United States ([@B2]). The Shiga toxins (Stx1 and Stx2) are important virulence factors expressed by STEC strains, but Stx2 exhibits the highest correlation to severe disease ([@B3]). The *stx* genes are generally carried on prophage integrated in the host bacterium chromosome.

*E. coli* O157:H7 strain B6914-MS1 (B6914) is a human fecal isolate that was identified by the Centers for Disease Control and Prevention (CDC), deposited into the American Type Culture Collection (ATCC), and made publicly available as strain ATCC 43888. Strain B6914 does not produce or carry the genes for Stx1 or Stx2 toxins and has been classified as a biosafety level one (BSL-1) organism according to the *Biosafety in Microbiological and Biomedical Laboratories* (BMBL) guidelines ([@B4]). Strain B6914 has been used extensively in applied research studies due its low potential for pathogenicity.

Clinical strains of serotype O157:H7 generally have attenuated biofilm properties as a result of prophage insertions in the *mlrA* gene, a transcription factor required for full expression of the central biofilm regulator, CsgD ([@B5]). A B6914 isolate from our collection (designated B6914-ARS) carries the *mlrA* prophage, but a recent study showed that biofilm formation was restored in that strain by prophage excisions at a higher than expected rate by an undetermined mechanism ([@B6]). Therefore, we have sequenced the entire genome of strain B6914-ARS to investigate the genetic mechanisms involved with biofilm production and/or other relevant phenotypes described in studies of B6914-MS1 derivatives.

Large DNA fragments for single-molecule real-time (SMRT) sequencing were extracted from a frozen cell pellet (from 5 mL of overnight culture) of B6914-ARS using the Qiagen Genomic-tip 100/G kit (Qiagen, Valencia, CA). SMRT sequencing was done at the University of Delaware Sequencing and Genotyping Center using the PacBio RS II SMRT DNA sequencing system (Pacific Biosciences, Menlo Park, CA). The *de novo* genome assembly was done with Hierarchical Genome Assembly Process 3.0 (HGAP 3.0) software, and the genome annotation was performed via the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) ([@B7]).

The unclosed B6914-ARS draft assembly consists of a predicted 5,537,960 paired-nucleotide chromosome in three contigs with a combined G+C content of 50.3% and a single large plasmid of 115,027 paired nucleotides with a G+C content of 48.2%. The PHASTER prophage locator and annotation tool identified 11 intact, 3 incomplete, and 3 questionable prophage regions ([@B8], [@B9]). A locus of enterocyte effacement (LEE) pathogenicity island with high similarity in genetic content and arrangement to that of O157:H7 outbreak strain Sakai ([@B10]) (GenBank accession number NC_002695) was also identified. The genes encoding the A and B subunits of both Stx1 and Stx2 are missing from the B6914-ARS genome. However, a prophage similar to SP15 (which carries Stx1 in Sakai) was identified in the proximal portion of the *mlrA* gene.
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This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession numbers [NOKN01000001](https://www.ncbi.nlm.nih.gov/nuccore/NOKN01000001) to [NOKN01000003](https://www.ncbi.nlm.nih.gov/nuccore/NOKN01000003) (chromosome) and [NOKN01000004](https://www.ncbi.nlm.nih.gov/nuccore/NOKN01000004) (plasmid). The versions described in this paper are the first versions.
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